Evidence map›Paper›PMID 28566944›Full record

ArticleDialogues in clinical neuroscience2017

In immune defense: redefining the role of the immune system in chronic disease.

Katya B Rubinow, David R Rubinow

Open access · diamondAbstract read
In one paragraph

Article in Dialogues in clinical neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Rethinking immune studies: population-level immune variations and the path forward.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Katya B RubinowDiabetes Institute, Department of Medicine, University of Washington, Seattle, Washington, USA.
David R RubinowDepartment of Psychiatry, University of North Carolina, Chapel Hill, North Carolina, USA.
University of North Carolina at Chapel Hill · USUniversity of Washington · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Identifying Biomarkers for Post-Partum Depression in African-American WomenR01MH095992 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUBINOW, DAVID R., SULLIVAN, PATRICK F · 2012 to 2015
$5.2M
Depression, Estrogen Replacement, and Cardiovascular Health in the PerimenopauseR01MH087619 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GIRDLER, SUSAN S., RUBINOW, DAVID R. · 2010 to 2014
$4.0M
Men's Reproductive Health Research at the Univ of WashingtonK12HD053984 · NICHD · UNIVERSITY OF WASHINGTON · PI BREMNER, WILLIAM J · 2006 to 2016
$2.9M
NICHD NIH HHS K12 HD053984NIDDK NIH HHS P30 DK017047NIMH NIH HHS R01 MH087619NIMH NIH HHS R01 MH095992
6 · The paper itself

Abstract

The recognition of altered immune system function in many chronic disease states has proven to be a pivotal advance in biomedical research over the past decade. For many metabolic and mood disorders, this altered immune activity has been characterized as inflammation, with the attendant assumption that the immune response is aberrant. However, accumulating evidence challenges this assumption and suggests that the immune system may be mounting adaptive responses to chronic stressors. Further, the inordinate complexity of immune function renders a simplistic, binary model incapable of capturing critical mechanistic insights. In this perspective article, we propose alternative paradigms for understanding the role of the immune system in chronic disease. By invoking allostasis or systems biology rather than inflammation, we can ascribe greater functional significance to immune mediators, gain newfound appreciation of the adaptive facets of altered immune activity, and better avoid the potentially disastrous effects of translating erroneous assumptions into novel therapeutic strategies.

Indexed as

Adaptation, PhysiologicalAllostasisChronic DiseaseHumansImmune SystemInflammationMetabolic DiseasesMood Disordersallostasisdepressiondiabetesimmunityinflammationobesity

Identifiers

PMID28566944
PMCPMC5442360
OpenAlexW2898243964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.